IRCT20231121060132N1招募中3 期
Investigating the effectiveness of famotidine as a radioprotector in reducing the mucosal and hematological complications of prostate cancer radiotherapy
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 75 years（—）
- 性别
- Male
入选标准
- •Patients aged 30 to 75 with prostate cancer candidates for radiotherapy
- •Do not receive PPI drugs and other H2 antagonist drugs
排除标准
- •Lack of consent to participate in the study
- •Patients with kidney disease that cannot be prescribed famotidine
研究者
相似试验
尚未招募
2 期
The effectiveness of adding famotidine and vitamin B6 to standard drug treatment in patients with schizophrenia disorderSchizophreniaIRCT20150822023705N16Kermanshah University of Medical Sciences80
已完成
1 期
Evaluation of the Radioprotective Effect of Famotidine Against Radiotherapy- induced Acute Toxicity in Patients with Prostate CancerBowel toxicityUrinary toxicityCancer - ProstateOral and Gastrointestinal - Normal oral and gastrointestinal development and functionRenal and Urogenital - Normal development and function of male and female renal and urogenital systemProstate CancerACTRN12612000101886School of Paramedical Sciences, Shahid Beheshti Medical University,36
招募中
Unknown
Bioequivalence study of Famotidine SuspensioIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N44Tabriz University of Medical Sciences24
已完成
3 期
Clinical trial on the effectiveness of the Famotidine on symptoms of schizophrenic patientsSchizophreniaIRCT20190707044123N1Rasht University of Medical Sciences64
招募中
3 期
Famotidine and COVID-19aboratory confirmed COVID-19.COVID-19, virus identifiedU07.1IRCT20200509047364N2Bandare-abbas University of Medical Sciences20